Ischemic cardiomyopathy is a weakened heart muscle caused by reduced blood flow, typically from coronary artery disease. The heart’s pumping ability drops significantly, with the left ventricle ejecting less than 40% of its blood with each beat (a healthy heart pumps out 55% or more). It is the most common cause of heart failure worldwide.
How Coronary Artery Disease Leads to a Weak Heart
The process starts with plaque buildup inside the coronary arteries, the vessels that feed oxygen and nutrients to the heart muscle itself. As these arteries narrow, parts of the heart become starved for oxygen. This can happen gradually over years of restricted blood flow or suddenly during a heart attack, when a plaque ruptures and blocks an artery completely.
Either way, oxygen-deprived heart muscle cells begin to die. The body replaces them with scar tissue, primarily made of stiff collagen fibers. Unlike healthy muscle, scar tissue cannot contract. Over time, the damaged areas thin out and stretch, and the heart’s main pumping chamber (the left ventricle) enlarges to compensate. This process is called cardiac remodeling. The ventricle gradually shifts from its normal oval shape toward a rounder, less efficient form, which makes each heartbeat weaker. It’s a self-reinforcing cycle: the weaker the pump, the more the chamber stretches, and the worse the pumping becomes.
Scar tissue also disrupts the heart’s electrical system. Electrical signals that normally travel in smooth, coordinated waves have to zigzag around patches of scarring. This creates conditions where abnormal heart rhythms can form, a risk that persists long after the original damage occurred.
What It Feels Like
Symptoms reflect the heart’s inability to pump enough blood to meet the body’s demands. The most common are:
- Shortness of breath, especially during physical activity or when lying flat
- Fatigue and low energy, even with routine tasks like climbing stairs or carrying groceries
- Swelling in the legs, ankles, or feet from fluid backing up in the body
- Chest pain or pressure, particularly with exertion
- Rapid or irregular heartbeat
These symptoms often develop gradually. Some people first notice they can’t exercise as long as they used to. Others feel winded doing things that were once easy. Because the decline can be slow, many people attribute early symptoms to aging or being out of shape, which delays diagnosis. In other cases, the first sign is a heart attack itself, and the cardiomyopathy is discovered during the workup that follows.
How Doctors Confirm the Diagnosis
The key finding is a left ventricular ejection fraction below 40% combined with evidence of coronary artery disease. An echocardiogram (an ultrasound of the heart) is usually the first test, showing how well the ventricle contracts and measuring the ejection fraction.
Cardiac MRI with a contrast agent offers a more detailed picture. The contrast collects in areas of scarring, lighting them up on the scan. This technique, called late gadolinium enhancement, can distinguish between ischemic and non-ischemic causes of heart failure based on where the scarring appears. Ischemic damage typically shows up in the inner layers of the heart wall or extends all the way through, following the territory of a blocked artery. Non-ischemic damage tends to appear in the middle of the wall or along the outer surface, a pattern that points to other causes like viral infection or genetic conditions. A scar extending through more than half the wall thickness in any segment is considered transmural, meaning full-thickness damage where recovery of that muscle is unlikely.
Coronary angiography, where dye is injected into the coronary arteries and viewed on X-ray, confirms the extent and location of blockages. Together, these tests tell doctors how much muscle is still viable and how much is permanently scarred, which directly shapes treatment decisions.
Medications That Slow the Decline
Drug therapy targets the cycle of remodeling that makes the heart progressively weaker. Several classes of medication work together, each addressing a different part of the problem.
ACE inhibitors (or a related class called ARBs) block hormonal signals that cause the heart to enlarge and stiffen. In a large analysis of nearly 100,000 heart attack patients, those treated with ACE inhibitors had a 7% lower mortality rate at 30 days compared to placebo. The benefit is strongest in people whose ejection fraction has dropped below 40% or who have other risk factors like diabetes or high blood pressure. For patients who also have heart failure symptoms or diabetes, adding a mineralocorticoid receptor antagonist on top of ACE inhibitors further reduces mortality.
Beta-blockers slow the heart rate and reduce how hard the heart works with each beat, lowering its oxygen demand. Clinical trials have shown they reduce the risk of repeat heart attacks and dangerous heart rhythms. SGLT2 inhibitors, originally developed for diabetes, have shown cardiovascular benefits in heart failure patients regardless of whether they have diabetes. In one trial, they reduced heart failure hospitalizations in people with impaired heart function after a heart attack.
Restoring Blood Flow
When significant blockages are present and viable heart muscle remains downstream, restoring blood flow can improve the heart’s pumping ability. There are two main approaches: stenting (where a small mesh tube is placed inside the artery to hold it open) and bypass surgery (where a blood vessel from elsewhere in the body is grafted around the blockage).
The choice between the two depends on the number and location of blockages, how much heart function has been lost, and the patient’s overall health. For people with extensive coronary disease affecting multiple vessels, bypass surgery has traditionally been favored. However, the optimal strategy for patients with severely reduced heart function remains an area without clear-cut answers from head-to-head trials. In practice, a heart team reviews each case individually.
The critical question is whether the muscle being supplied by a blocked artery is still alive or has been replaced by scar. Viable muscle that’s “hibernating” from lack of blood flow can recover function once flow is restored. Scarred muscle will not. This is why the imaging tests described above, particularly cardiac MRI, play such a central role in planning treatment.
Preventing Sudden Cardiac Death
Scar tissue in the heart creates electrical “short circuits” that can trigger life-threatening rhythm disturbances. The border zone between healthy muscle and scar is especially dangerous: electrical signals slow down as they navigate around obstacles, creating the conditions for a type of rhythm called ventricular tachycardia, where the lower chambers beat dangerously fast.
For patients whose ejection fraction remains below 35% despite optimal medical therapy, current guidelines recommend an implantable cardioverter-defibrillator (ICD). This small device, placed under the skin near the collarbone, continuously monitors heart rhythm and delivers a corrective shock if it detects a dangerous arrhythmia. It remains the most effective tool for preventing sudden cardiac death in this population. The timing of risk assessment matters: doctors typically evaluate the need for an ICD after medications and any revascularization procedures have had time to take effect, though earlier assessment is warranted if there are warning signs like fainting episodes or abnormal rhythms on monitoring.
Living With Ischemic Cardiomyopathy
Cardiac rehabilitation is one of the most effective but underused interventions. These supervised programs combine structured physical activity with education on nutrition, medication management, and smoking cessation. For people with weakened hearts, the benefits are concrete: improved energy, greater strength, and the ability to handle everyday tasks that heart failure can make exhausting. Older adults in particular benefit from the gains in mobility and independence.
Beyond formal rehab, managing ischemic cardiomyopathy means controlling the risk factors that caused the coronary artery disease in the first place. That includes keeping blood pressure and cholesterol in range, maintaining a healthy weight, staying physically active within your capacity, and limiting sodium intake to reduce fluid retention. Daily weight monitoring helps catch fluid buildup early, since a gain of two or more pounds overnight often signals worsening heart failure before other symptoms appear.
The trajectory of the disease varies widely. Some people stabilize with medications and lifestyle changes, maintaining a good quality of life for years. Others progress despite treatment and may eventually need advanced therapies like a mechanical heart pump or transplant evaluation. The extent of scarring, how early treatment begins, and how consistently medications are taken all influence the outcome.